Systemic therapy for breast cancer and risk of subsequent contralateral breast cancer in the WECARE Study

BACKGROUND: Treatment with tamoxifen or chemotherapy reduces the risk of contralateral breast cancer (CBC). However, it is uncertain how long the protection lasts and whether the protective effect is modified by patient, tumor, or treatment characteristics. METHODS: The population-based WECARE Study...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Breast Cancer Res
Autori principali: Langballe, Rikke, Mellemkjær, Lene, Malone, Kathleen E., Lynch, Charles F., John, Esther M., Knight, Julia A., Bernstein, Leslie, Brooks, Jennifer, Andersson, Michael, Reiner, Anne S., Liang, Xiaolin, Woods, Meghan, Concannon, Patrick J., Bernstein, Jonine L.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4940926/
https://ncbi.nlm.nih.gov/pubmed/27400983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-016-0726-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi